Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J.A. Barbera (Barcelona, Spain). Vascular remodelling in COPD. Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms

Member's Comments

No comment yet.

Related content which might interest you: Hypoxia-induced pulmonary hypertension Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms Year: 2007 COPD Research Awardee 2012 - Exacerbations of COPD Source: Annual Congress 2012 - ERS COPD Research Award Ceremony (supported by Boehringer Ingelheim) followed by the Hot Topic "It takes two to tango: innate and adaptive immunity in COPD" Year: 2012 Pulmonary vessels remodeling in COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Vascular endothelial growth factor (VEGF) as marker of pulmonary hypertension in children with asthma Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Gene regulation in emphysema Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms Year: 2007 Clinical picture analysis of idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) concomitance in the population of patients hospitalized in Ist Clinic of Lung Diseases Institute for Tuberculosis and Lung Diseases in Warsaw, Poland in the years 1994-2009 Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Relationship between endothelial dysfunction and GOLD stage in patients with COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Hospitalisations for exacerbations of COPD, France, 1998-2007 Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls Source: International Congress 2016 – Systemic biomarkers Year: 2016 Pulmonary hypertension: where are we in 2007? Source: ERS Live 2007 Year: 2007 Remodeling of bronchial and pulmonary muscular arteries in mild/moderate COPD Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014 Asthma exacerbation triggers in Novosibirsk children from 1982 to 2002 Source: Eur Respir J 2003; 22: Suppl. 45, 289s Year: 2003 Role of NMDA receptors in vascular remodelling associated to pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 ASK1 promotes maladaptive remodeling in a rodent model of pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Effect of pulmonary hemodynamics on the prognosis of patients with emphysematous COPD after LVRS Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Lung mechanics 1954-2004 Source: Annual Congress 2004 - The First European Respiratory Meeting, 50 years on Year: 2004 Histological correlates of vascular density analysis by computer tomography in chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced COPD Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Endothelial-to-mesenchymal transition in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014